Kaken Pharmaceutical (Japan)

531 papers and 11.5k indexed citations i.

About

In recent decades, authors affiliated with Kaken Pharmaceutical (Japan) have published 531 papers, which have received a total of 11.5k indexed citations. Scholars at this organization have produced 173 papers in Molecular Biology, 74 papers in Organic Chemistry and 59 papers in Pharmacology on the topics of Analytical Chemistry and Chromatography (22 papers), Nail Diseases and Treatments (22 papers) and Drug Transport and Resistance Mechanisms (21 papers). Their work is cited by papers focused on Molecular Biology (4.3k citations), Organic Chemistry (1.4k citations) and Cell Biology (1.2k citations). Authors at Kaken Pharmaceutical (Japan) collaborate with scholars in Japan, United Kingdom and United States and have published in prestigious journals including Journal of Biological Chemistry, Advanced Materials and Journal of Neuroscience. Some of Kaken Pharmaceutical (Japan)'s most productive authors include T. Nakamura, M Ui, T. Nakamura, Makoto Tamura, Keigo Hanada, Arnold I. Caplan, James E. Dennis, T. Kawasaki, Shoichi Takahashi and Michio Ui.

In The Last Decade

Fields of papers published by authors at Kaken Pharmaceutical (Japan)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Kaken Pharmaceutical (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Kaken Pharmaceutical (Japan) at the time of their publication.

Countries citing scholars working at Kaken Pharmaceutical (Japan)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Kaken Pharmaceutical (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Kaken Pharmaceutical (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaken Pharmaceutical (Japan) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025